Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Board memberships
- AN2 Therapeutics, Inc.
Updated Jul 16, 2026
Aziz Kabeer has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 2.9K | $0.00 | |
| 2026-04-11 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 3.8K | $0.00 | |
| 2026-01-14 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 11.6K | $0.00 | |
| 2025-10-10 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 10.4K | $0.00 | |
| 2025-07-10 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 11.9K | $0.00 | |
| 2024-12-23 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 9.0K | $0.00 |
Aziz Kabeer is a corporate insider — currently tracked as Insider of AN2 Therapeutics, Inc. (ANTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Aziz Kabeer profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.